Skip to main content
BiotoxtechCo.,Ltd. logo

BiotoxtechCo.,Ltd. — Investor Relations & Filings

Ticker · 086040 ISIN · KR7086040003 KO Professional, scientific and technical activities
Open in API
Filings indexed 172 across all filing types
Latest filing 2026-03-27 Declaration of Voting R…
Country KR South Korea
Listing KO 086040

About BiotoxtechCo.,Ltd.

http://eng.biotoxtech.com/

Biotoxtech Co., Ltd. is a non-clinical Contract Research Organization (CRO) that provides safety and efficacy evaluation services. The company offers a comprehensive suite of GLP-compliant studies, including general toxicity, carcinogenicity, reproductive and developmental toxicity, genotoxicity, immunotoxicity, and safety pharmacology. It also conducts efficacy evaluations and provides analytical research services such as pharmacokinetics (PK/TK/ADME) and bioanalysis. Biotoxtech serves a diverse clientele developing pharmaceuticals, biomedicines, cell and gene therapies, medical devices, chemicals, agrochemicals, cosmetics, and health functional foods.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document text is in Korean and clearly titled 정기주주총회결과 (Annual General Meeting Results) with detailed voting outcomes for each agenda item, including approval of financial statements, director appointments, and voting rates. It discloses the results of shareholder votes and related meeting information. This matches the definition of “Declaration of Voting Results & Voting Rights Announcements” (Code: DVA).
2026-03-27 Korean
사업보고서 (2025.12)
Annual Report Classification · 1% confidence The document is a comprehensive 'Audit Report' (감사보고서) for Biotoxtech Co., Ltd. for the fiscal year ending December 31, 2025. It includes the independent auditor's report, consolidated financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. While it contains audit information, it is a full financial report package rather than a standalone audit opinion letter, and it contains substantive financial data, making it an 'Annual Report' or 'Interim/Quarterly Report' equivalent. Given the comprehensive nature of the financial statements for the full fiscal year, it is classified as an Annual Report (10-K). FY 2025
2026-03-19 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a regulatory filing from the Korea Exchange (KRX) system titled '감사보고서 제출' (Submission of Audit Report). It provides a summary of the audit opinion (unqualified/appropriate), key financial data (assets, liabilities, equity, profit/loss), and auditor information. While it contains financial data, it is a standardized regulatory disclosure form summarizing the audit results rather than the full 10-K annual report itself. Therefore, it is classified as an Audit Report/Information document. FY 2025
2026-03-19 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Biotoxtech. It outlines the date, location, agenda items (such as approval of financial statements, election of directors, and remuneration limits), and details regarding the director nominee. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the upcoming meeting and the matters to be voted upon.
2026-03-12 Korean
주주총회집중일개최사유신고
AGM Information Classification · 1% confidence The document is a formal regulatory filing submitted by Biotoxtech regarding the scheduling of their Annual General Meeting (AGM) on a 'concentrated date' (a date where many companies hold their AGMs). It explains the reasons for this scheduling conflict and provides details on the meeting date and notice date. Since it is a regulatory announcement regarding meeting logistics rather than the meeting materials themselves or a report, it falls under the general regulatory filing category.
2026-03-12 Korean
주주총회소집공고
AGM Information Classification · 1% confidence The document is a formal 'Notice of Annual General Meeting' (주주총회소집공고) for Biotoxtech Co., Ltd. It outlines the meeting date, location, agenda items (including financial statement approval, director appointments, and remuneration limits), and voting procedures. While it contains financial data, this is provided as part of the meeting materials for shareholders to review prior to the vote, which is characteristic of AGM information packages.
2026-03-12 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.